BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Cancer Epigenetics Society - ECPv5.3.2.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Cancer Epigenetics Society
X-ORIGINAL-URL:https://ces.b2sg.org
X-WR-CALDESC:Events for Cancer Epigenetics Society
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20180325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20181028T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180407
DTEND;VALUE=DATE:20180509
DTSTAMP:20260729T095935
CREATED:20180407T084819Z
LAST-MODIFIED:20180407T084819Z
UID:19853-1523059200-1525823999@ces.b2sg.org
SUMMARY:Research Fellow
DESCRIPTION:Two fully funded post-doctoral positions are available in the lab of Dr. Carl Novina in the Cancer Immunology and Virology Program at Dana-Farber Cancer Institute (http://novinalab.dana-farber.org/). The positions are available for the translation of (1) autologous T cell therapies for solid tumors including chimeric antigen receptors (CAR-T cells) and (2) targeted epigenetic reprogramming of immune cells.\nSuccessful candidates will work in a collaborative and entrepreneurial team of researchers and clinicians to develop and evaluate the efficacy of novel cell and molecular therapies.\nInterested individuals should submit a cover letter and curriculum vitae and contact information for three references.\n\n\n\nQualifications\n\n\n\nCandidates should have a PhD or MD/PhD in immunology or a related field and at least one first author peer-reviewed publications\, with significant experience in standard immunological assays. Expertise in neuroimmunology\, immunotherapy\, and/or human immunobiolgy preferred.
URL:https://ces.b2sg.org/event/df-7apr18/
LOCATION:Dana-Farber Cancer Institute\, 450 Brookline Avenue\, Boston\, MA\, 02215\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/11/Dana-Farber.jpg
END:VEVENT
END:VCALENDAR